XML 40 R30.htm IDEA: XBRL DOCUMENT v3.22.2
Stock and Incentive Compensation Plans (Tables)
6 Months Ended
Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Compensation Cost Charged to Income
Share-based compensation cost charged to income for the three and six months ended June 30, 2022 and 2021, is presented below. There was no stock option expense for any of the periods shown.
Three Months Ended June 30,Six Months Ended June 30,
(Dollars in thousands)2022202120222021
RSA & RSU$666 $444 $1,277 $1,058 
PSU103 — 149 — 
ESPP72 27 153 27 
Total stock compensation expense$841 $471 $1,579 $1,085 
Related tax benefits recognized in net income$177 $99 332 228 
Schedule of Time-Vested Award Activity
The following table summarizes the Company's award activity:
Six Months Ended June 30,
20222021
SharesWeighted Average Grant-Date Fair ValueSharesWeighted Average Grant-Date Fair Value
Nonvested RSA shares, January 1,48,048 $35.27 103,359 $31.51 
Granted RSA12,840 37.39 19,617 40.47 
Vested RSA(19,524)36.61 (40,281)26.45 
Forfeited RSA— — (946)24.69 
Nonvested RSA shares, June 30,41,364 35.29 81,749 36.23 
Nonvested RSU, January 1,73,977 $40.64 — $— 
Granted RSU61,081 42.28 — — 
Forfeited RSU(743)40.40 — — 
Nonvested RSU, June 30134,315 41.39 — — 
Nonvested PSU, January 1— $— — $— 
Granted PSU27,632 44.77 — — 
Nonvested PSU, June 3027,632 44.77 — — 
Schedule of Stock Option Activity
The table below summarizes the status of the Company's stock options and changes during the six months ended June 30, 2022 and 2021.
(Dollars in thousands, except per share amounts)Number of SharesWeighted Average Exercise PriceWeighted Average Remaining Contractual Term
 (in years)
Aggregate Intrinsic Value
Six Months Ended June 30, 2022
Outstanding at January 1, 202239,200 $10.73 2.28$1,262 
Exercised(24,800)9.23 — — 
Outstanding and exercisable at June 30, 2022
14,400 13.31 1.52367 
Six Months Ended June 30, 2021
Outstanding at January 1, 2021224,000 $10.86 4.92$3,789 
Exercised(14,800)9.89 — — 
Outstanding and exercisable at June 30, 2021
209,200 10.93 4.816,597